These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 36895966

  • 1. N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma.
    Xu F, Cai D, Liu S, He K, Chen J, Qu L, Chong T, Li X, Ren B.
    Am J Cancer Res; 2023; 13(2):538-568. PubMed ID: 36895966
    [Abstract] [Full Text] [Related]

  • 2. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K, Yang J, Li X, Xiong W, Zhang P, Zhang X.
    Front Surg; 2022; 9():893977. PubMed ID: 35784919
    [Abstract] [Full Text] [Related]

  • 3. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
    Li R, Liu X, Deng K, Wang X.
    BMC Med Genomics; 2023 Aug 01; 16(1):179. PubMed ID: 37528384
    [Abstract] [Full Text] [Related]

  • 4. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
    He CM, Zhang XD, Zhu SX, Zheng JJ, Wang YM, Wang Q, Yin H, Fu YJ, Xue S, Tang J, Zhao XJ.
    Front Genet; 2022 Aug 01; 13():998147. PubMed ID: 36226166
    [Abstract] [Full Text] [Related]

  • 5. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
    Li T, Chen Z, Wang Z, Lu J, Chen D.
    Front Immunol; 2023 Aug 01; 14():1260195. PubMed ID: 37868988
    [Abstract] [Full Text] [Related]

  • 6. Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma.
    Wang H, Shui X, Zhang Z, He M, Tai S, Lin Y.
    Transl Cancer Res; 2024 Jun 30; 13(6):2799-2811. PubMed ID: 38988942
    [Abstract] [Full Text] [Related]

  • 7. WDR4 promotes HCC pathogenesis through N7-methylguanosine by regulating and interacting with METTL1.
    Dong R, Wang C, Tang B, Cheng Y, Peng X, Yang X, Ni B, Li J.
    Cell Signal; 2024 Jun 30; 118():111145. PubMed ID: 38493882
    [Abstract] [Full Text] [Related]

  • 8. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q, Huang B, Pan J, Mao X.
    Cancer Cell Int; 2023 May 08; 23(1):85. PubMed ID: 37158958
    [Abstract] [Full Text] [Related]

  • 9. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
    Maimaiti A, Feng Z, Liu Y, Turhon M, Xie Z, Baihetiyaer Y, Wang X, Kasimu M, Jiang L, Wang Y, Wang Z, Pei Y.
    Eur J Med Res; 2023 Mar 30; 28(1):144. PubMed ID: 36998056
    [Abstract] [Full Text] [Related]

  • 10. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J, Liang Y, Gu JJ, Huang Y, Wang B.
    Front Genet; 2022 Mar 30; 13():991162. PubMed ID: 36353118
    [Abstract] [Full Text] [Related]

  • 11. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J, Wang H, Yao Y, Wu Z, Chen L, Jin C, Shi Z, Wu C, Hu X.
    Aging (Albany NY); 2022 Jun 29; 14(12):5233-5249. PubMed ID: 35771136
    [Abstract] [Full Text] [Related]

  • 12. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J.
    J Gastrointest Oncol; 2022 Dec 29; 13(6):3169-3182. PubMed ID: 36636051
    [Abstract] [Full Text] [Related]

  • 13. A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma.
    Duan HP, Yan JH, Nie L, Wang Y, Xie H.
    BMC Pulm Med; 2023 Jan 12; 23(1):14. PubMed ID: 36635678
    [Abstract] [Full Text] [Related]

  • 14. m7G Methyltransferase METTL1 Promotes Post-ischemic Angiogenesis via Promoting VEGFA mRNA Translation.
    Zhao Y, Kong L, Pei Z, Li F, Li C, Sun X, Shi B, Ge J.
    Front Cell Dev Biol; 2021 Jan 12; 9():642080. PubMed ID: 34136476
    [Abstract] [Full Text] [Related]

  • 15. Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma.
    Yan X, Zheng W, Xu FS, Chang HL, Zhang Y, Zhang ZY, Zhang YH.
    Eur Rev Med Pharmacol Sci; 2024 Mar 12; 28(5):2024-2050. PubMed ID: 38497885
    [Abstract] [Full Text] [Related]

  • 16. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma.
    Ke C, Dai S, Xu F, Yuan J, Fan S, Chen Y, Yang L, Li Y.
    BMC Cancer; 2023 Jan 07; 23(1):25. PubMed ID: 36611155
    [Abstract] [Full Text] [Related]

  • 17. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J, Li K, Chen J, Wang X, Ling R, Cheng M, Chen Z, Chen F, He Q, Li S, Zhang C, Jiang Y, Chen Q, Wang A, Chen D.
    Cancer Commun (Lond); 2022 Mar 07; 42(3):223-244. PubMed ID: 35179319
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
    Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S.
    Front Genet; 2022 Mar 07; 13():906496. PubMed ID: 35938009
    [Abstract] [Full Text] [Related]

  • 19. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
    Yang S, Zhou J, Chen Z, Sun Q, Zhang D, Feng Y, Wang X, Sun Y.
    Front Oncol; 2022 Mar 07; 12():934928. PubMed ID: 35992788
    [Abstract] [Full Text] [Related]

  • 20. Identification of N7-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma.
    Ma X, Yang B, Yang Y, Wu G, Ma X, Yu X, Li Y, Wang Y, Guo Q.
    Front Genet; 2022 Mar 07; 13():946845. PubMed ID: 36105111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.